This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignee: Emendobio Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Michal Golan-Mashiach: Innovator in RNA Technology
Introduction
Michal Golan-Mashiach is a prominent inventor based in Ness-Ziona, Israel. He has made significant contributions to the field of RNA technology, holding a total of four patents. His work focuses on innovative methods and compositions that have the potential to impact genetic research and therapeutic applications.
Latest Patents
Golan-Mashiach's latest patents include groundbreaking advancements in RNA molecules. One of his notable patents is for a differential knockout of an allele of a heterozygous fibrinogen alpha chain (FGA) gene. This patent involves RNA molecules comprising a guide sequence portion with 17-20 nucleotides, which can be utilized in various compositions, methods, and applications. Another significant patent targets a mutant human inosine monophosphate dehydrogenase I allele, also involving RNA molecules with a similar guide sequence structure.
Career Highlights
Throughout his career, Michal Golan-Mashiach has been associated with Emendobio Inc., where he has been able to apply his expertise in RNA technology. His innovative approach has led to the development of new methodologies that enhance the understanding of genetic mechanisms.
Collaborations
Golan-Mashiach has collaborated with notable colleagues, including Lior Izhar and David Baram. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
In summary, Michal Golan-Mashiach is a distinguished inventor whose work in RNA technology has led to significant advancements in genetic research. His contributions through patents and collaborations continue to shape the future of this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile